Locations:
Search IconSearch

News & Insight

TFRT_650x450
March 22, 2019/Cancer/News & Insight

Time-to-Treat, Two Years Later

Our Cancer Center Chair reflects on progress and potential

20496714399_9d12e253e1_z_650x450
February 4, 2019/Cancer/News & Insight

Electronic Brachytherapy: Is It a Viable Option?

Why experts advise against it for breast, skin and gynecologic cancers

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Castleman disease
December 19, 2018/Cancer/News & Insight

Treatment Guidelines Established for Idiopathic Multicentric Castleman Disease

An international consensus statement on a subtype of a rare disease

Breast-cancer_650x450
December 5, 2018/Cancer/News & Insight

Adjuvant T-DM1 Superior to Trastuzumab in Patients with HER2+ Early Breast Cancer

Increased invasive disease-free survival, disease-free survival and overall survival

pancreatic-cancer_650x450
November 21, 2018/Cancer/News & Insight

ASCO Updates Guidelines for Patients with Metastatic Pancreatic Cancer

New recommendations for second-line therapy

PET imaging

Functional PET Imaging to Identify Prostate Cancer Treatment Resistance

Research has clear implications for future of prostate cancer imaging

Breast cancer cell
September 26, 2018/Cancer/News & Insight

Encouraging Progress in Immunotherapy for Breast Cancer

Trial may lead to first FDA approval in this realm

nci-vol_650x450
July 27, 2018/Cancer/News & Insight

A One-Day Melanoma Refresh with Cleveland Clinic Experts

Complimentary case-based program Aug. 24

BackPage 8 of 10Next

Advertisement

Ad